id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ecj-8838	Casagranda, Ivo; Ungar, Andrea; Prevaldi, Carolina; Abete, Pasquale; Biagioni, Sergio; Del Rosso, Attilio; Diamanti, Michele; Fanciulli, Alessandra; Fumagalli, Stefano; Furlan, Raffaello; Lerza, Roberto; Locatelli, Carlo; Maggi, Roberto; Mussi, Chiara; Numeroso, Filippo; Rabajoli, Filippo; Testa, Sophie; Tomaino, Marco; Brignole, Michele	Anticoagulation therapy in older patients at risk for syncopal and not-syncopal fall and/or frailty. An AcEMC-GIMSI multidisciplinary consensus document	2020	5	.pdf	application/pdf	3605	219	57	Despite being at an increased risk of thromboembolic events because of non-valvular AF, frail patients appear less likely to receive adequate OAT com- pared with non-frail patients.16-18 Frailty is associated with a higher cardio- and cerebrovascular risk,19 and net clinical benefit of OAT is higher in frail older patients than in non-frail elderly patients.20 For this reason, despite the common clinical practice, frail patients have a clear indication to OAT. Steffel J, Giugliano RP, Braunwald E, et al. Edoxaban versus warfarin in atrial fibrillation patients at risk of falling: ENGAGE AF-TIMI 48 Analysis.	cache/ecj-8838.pdf	txt/ecj-8838.txt